Search

Aleta Biotherapeutics' Paul Rennert on what he sees is working, and what isn't, at #SITC23
Paul Rennert gives an update on Aleta, and summarizes data at #SITC23 from the IO 2.0, cytokine, TGF beta, Treg, lymphoid, and CAR-T spaces.
Nov 4, 2023

The CEO of Marengo Therapeutics talks about his company's focus on activating and expanding T-cells
Zen Su gives an overview Marengo, his view of #SITC23, and SITC's new biotech initiative.
Nov 4, 2023